NXTC: NextCure, Inc. Stock

by  •  • Comments Off on NXTC: NextCure, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 8.19
Enterprise Value ($M) -19.54
Book Value ($M) 65.47
Book Value / Share 2.34
Price / Book 0.13
NCAV ($M) 56.42
NCAV / Share 2.01
Price / NCAV 0.15

Profitability (mra)
Return on Invested Capital (ROIC) -0.78
Return on Assets (ROA) -0.48
Return on Equity (ROE) -0.56

Liquidity (mrq)
Quick Ratio 7.50
Current Ratio 7.50

Balance Sheet (mrq) ($M)
Current Assets 71.81
Assets 80.86
Liabilities 15.39
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -57.21
Net Income -55.65
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -40.80
Cash from Investing 55.31
Cash from Financing 0.14

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Logos Global Management LP 0.00 -100.00
11-13 13G/A Affinity Asset Advisors, LLC 8.22 37.65

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-06 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-10 30,893 961,352 3.21
2025-04-09 66,233 523,255 12.66
2025-04-08 10,483 235,184 4.46
2025-04-07 700 49,478 1.41

(click for more detail)

Similar Companies
NMRA – Neumora Therapeutics, Inc. NUVL – Nuvalent, Inc.
NVAX – Novavax, Inc. OGI – Organigram Global Inc.
OLMA – Olema Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io